Pharmacotherapy for pregnant women — evidence summary

Summary of the evidence

Rating:
Beneficial

Evidence-based international guidelines (WHO, 2014) do not recommend pharmacotherapy for routine treatment of dependence to stimulants and cannabis in pregnant women

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option:
Pharmacotherapy
Desired outcome(s):
retain patients in treatment
Area(s)
Treatment
Specific substance or pattern of use:
cannabis
Target group(s) or setting(s):
pregnant women

Explore all resources in the Best practice portal

Best practice evidence summaries

Collaborations and partnerships in best practice

logo of the cochrane collaboration  grade logo   grade logo  Health Evidence Network, WHO Europe